Income statement, balance sheet and cash flow statement for the last 8 fiscal years, taken from the XBRL data EvoAir Holdings Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
0.77
1.19
0.39
0.31
0.28
Cost of revenue
0.5
0.95
0.42
0.32
0.3
Gross profit
0.27
0.24
-0.04
-0.01
-0.02
Selling and marketing
0.03
0.04
0.03
0.06
0.02
General and administrative
0
0.02
0.01
1.38
4.81
6.06
26.3
14.9
Operating expenses
0.01
1.41
4.86
6.1
26.3
15
Operating income
-1.14
-4.62
-6.13
-26.3
-15
Other non-operating income
-0.02
-0.94
-0.18
0
0.02
Pre-tax income
-0
-0.02
-0.01
-1.17
-5.56
-6.32
-26.3
-15
Net income to minority interests
-0.08
-0.32
-0.26
-0.44
-0.34
Net income
-0
-0.02
-0.01
-1.08
-5.23
-6.06
-25.9
-14.6
EBITDA
-1.12
-4.52
-6
-26.1
-14.9
EPS, basic
0.00
-0.04
0.00
-1.48
-0.32
-0.24
-1.01
-0.55
EPS, diluted
0.00
-0.04
0.00
-0.08
-0.32
-0.24
-1.01
-0.55
Shares, basic (weighted)
0.75
0.74
15.5
25.5
25.7
26.8
Shares, diluted (weighted)
0.02
0.61
0.75
0.74
15.5
25.5
25.7
26.8
Balance sheet
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
0.01
0.02
0.01
1.71
0.15
0.78
0.15
0.09
Receivables
0
0.13
0.09
0.04
0.06
0.06
Inventory
0.14
0.62
0.63
0.46
0.32
Other current assets
0
0
Total current assets
0.01
0.02
0.01
3.22
1.69
2.07
0.79
0.53
Property, plant and equipment
0
0
0
0.14
0.6
0.46
0.36
0.26
Lease right-of-use assets
0.44
0.27
0.2
0.09
Intangible assets
80.4
76.2
51.5
41.6
Total assets
0.01
0.02
0.01
3.36
83.1
79
53.3
45.7
Accounts payable
0
0
0.1
0.04
0.04
0.15
0.22
Accrued liabilities
0.01
0.01
0.01
0.01
0.13
0.13
0.11
0.32
Deferred revenue
0.43
0.51
0.44
0.01
0.01
Total current liabilities
0.01
0.01
0.01
1.64
0.89
0.96
1.68
3.21
Lease liabilities
0.36
0.2
0.11
0.03
Total liabilities
0.01
0.02
0.01
1.67
1.27
1.17
1.8
3.25
Paid-in capital
0
0.02
0.02
2.89
89.1
90.4
91.5
97.5
Retained earnings
-0
-0.02
-0.03
-2.23
-7.47
-13.5
-39.4
-54
Treasury stock
-0
Other comprehensive income
0.01
0.07
-0.02
-0.05
-0.09
Shareholders' equity
0.03
0.01
-0.01
-0.05
Minority interests
0.17
-0.06
-0.15
-0.61
-0.96
Total equity
0
0.01
-0.43
1.7
81.8
77.9
51.5
42.4
Total liabilities and equity
0
0.01
0.01
3.36
83.1
79
53.3
45.7
Shares outstanding
0.57
0.74
0.74
0.74
25.5
25.6
25.7
27.2
Cash flow statement
FY2019
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-0
-0.02
-0.01
-1.17
-5.56
-6.32
-26.3
-15
Depreciation and amortization
0
0
0.03
0.1
0.13
0.25
0.11
Stock-based compensation
3.26
Change in receivables
-0.09
0.04
0.04
-0.02
0.01
Change in inventory
-0.05
-0.48
-0.01
0.17
0.14
Change in payables
0
0
Cash from operations
-0
-0.02
-0.01
-2
-1.54
-1.67
-0.94
-1.16
Capital expenditures
-0.09
-0.56
-0.01
-0.15
-0.02
Cash from investing
0
-0
0
-0.09
-0.56
-0.01
-0.15
-0.02
Stock issued
0
0.02
0
0.19
1.14
Share buybacks
0
-0
Cash from financing
0.01
0.02
0
3.29
0.45
2.39
0.51
1.17
Net change in cash
0.01
0
-0.01
1.19
-1.65
0.7
-0.57
-0.01
Free cash flow
-2.1
-2.1
-1.69
-1.09
-1.18
Interest paid
0
0
0
Income taxes paid
0
0
0
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to May 31, 2026; growth uses fiscal years. Valuation uses the share price of $23.00 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
-0.4%
Gross profit / revenue.
Operating margin
-3,271.0%
Operating income / revenue.
EBITDA margin
-3,235.0%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-3,271.0%
Pre-tax income / revenue.
Net margin
-3,179.0%
Net income / revenue.
Operating cash flow margin
-368.9%
Cash from operations / revenue.
Return on assets (ROA)
-24.5%
Net income / average total assets.
D&A / revenue
35.5%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-9.5%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-37.9%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets growth, 1y
-14.2%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-18.1%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
497.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
4.5%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
19.9%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
104.6%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.10x
Current assets / current liabilities.
Quick ratio
0.02x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.01x
(Cash + short-term investments) / current liabilities.
Liabilities / assets
10.1%
Total liabilities / total assets.
Working capital
-$4.0M
Current assets - current liabilities.
Goodwill and intangibles / assets
90.9%
(Goodwill + intangible assets) / total assets.
Efficiency
Metric
Value
How it is calculated
Asset turnover
0.01x
Revenue / average total assets.
Fixed asset turnover
1.48x
Revenue / average property, plant and equipment.
Inventory turnover
1.08x
Cost of revenue / average inventory.
Days inventory
336 days
365 x average inventory / cost of revenue.
Receivables turnover
9.76x
Revenue / average receivables.
Days sales outstanding
37 days
365 x average receivables / revenue.
Days payables
265 days
365 x average accounts payable / cost of revenue.
Cash conversion cycle
109 days
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$0.39
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Market cap + total debt - cash - short-term investments.
P/S
1,861x
Market cap / revenue.
EV/Sales
1,861x
Enterprise value / revenue.
Earnings yield
-1.7%
Net income / market cap (the inverse of P/E).
What was EvoAir Holdings Inc.'s revenue in fiscal 2025?
EvoAir Holdings Inc. reported revenue of $284.7K for fiscal 2025, 9.5% lower than the year before.
Was EvoAir Holdings Inc. profitable in fiscal 2025?
No. It reported a net loss of $14.6M.
How much free cash flow did EvoAir Holdings Inc. generate in fiscal 2025?
Cash from operations of $1.2M minus capital expenditures of $17.0K left free cash flow of -$1.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.